TG101348 slightly decreased red blood cell counts and hemoglobin content in both WT and Apoe−/− mice, consistent with anemia as a detected adverse effect of fedratinib in MPN therapy in clinical trials [32]. The gene discussed is APOE; the disease is myeloproliferative neoplasm.